Characteristics of, and risk factors for, infections in patients with cancer treated with dasatinib and a brief review of other complications.
about
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaRisk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase InhibitorsSecond-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukaemia (CML).Tyrosine kinase inhibitors: potential use and safety considerations in HIV-1 infection.Inclusion body myositis in a patient with chronic myeloid leukemia treated with dasatinib: a case report
P2860
Characteristics of, and risk factors for, infections in patients with cancer treated with dasatinib and a brief review of other complications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Characteristics of, and risk f ...... review of other complications.
@en
Characteristics of, and risk f ...... review of other complications.
@nl
type
label
Characteristics of, and risk f ...... review of other complications.
@en
Characteristics of, and risk f ...... review of other complications.
@nl
prefLabel
Characteristics of, and risk f ...... review of other complications.
@en
Characteristics of, and risk f ...... review of other complications.
@nl
P2093
P2860
P1433
P1476
Characteristics of, and risk f ...... review of other complications.
@en
P2093
Amar Safdar
Fadi Al-akhrass
Gilhen H Rodriguez
Saud I Ahmed
Vijayashri Rallapalli
P2860
P304
P356
10.3109/10428194.2012.656626
P577
2012-02-21T00:00:00Z